Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Journal of Diabetes and Metabolic Disorders|July 5, 2021
Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The NetherlandsRick I Meijer, Trynke Hoekstra, Niels C Gritters van den Oever, et al.Diabetes, Obesity & Metabolism|September 28, 2021
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trialMarcel H A Muskiet, Lennart Tonneijck, Mark M Smits, et al.Diabetes & Metabolism|January 11, 2021
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetesMark M Smits, Kristina S Fluitman, Hilde Herrema, et al.Journal of Diabetes and Its Complications|January 24, 2022
Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trialsAnne C Hesp, Mark M Smits, Erik J M van Bommel, et al.Journal of Hypertension|June 10, 2020
Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetesErik J M van Bommel, Mark M Smits, Danique Ruiter, et al.Diabetologia|September 16, 2016
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trialMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.Annals of Epidemiology|March 29, 2013
Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysisMark M Smits, Pier Woudstra, Kristina M Utzschneider, et al.American Journal of Physiology. Renal Physiology|October 25, 2018
Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitusLennart Tonneijck, Marcel H A Muskiet, Charles J Blijdorp, et al.Diabetes Care|September 9, 2020
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind TrialMarcel H A Muskiet, Lennart Tonneijck, Mark M Smits, et al.American Journal of Physiology. Renal Physiology|April 26, 2021
Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney functionDaan M van Velzen, Mark M Smits, Erik J M van Bommel, et al.Pageof 7